---
title: Dipharma vs ESTEVE CDMO
slug_a: dipharma
slug_b: esteve-cdmo
site: cdmo
review_signal_gate: closed
canonical_path: /compare/dipharma/esteve-cdmo
---

# Dipharma vs ESTEVE CDMO

Side-by-side profile data from each company listing on this directory.

## Dipharma

- Profile: [/companies/dipharma](/companies/dipharma)

Dipharma — Global CDMO and API manufacturer with 600 employees, 4 cGMP plants, and 75+ years of experience in hazardous chemical synthesis, offering exclusive synthesis services and catalogue APIs with FDA, AIFA, and PMDA inspections since 1970.

Services: 6. Modalities: 1. Indications: 0. Locations: 3. Certifications: 0. The strongest documented coverage currently appears in services (6).

### Services

- API Synthesis & Manufacturing
- Process Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- CMC Regulatory Submission Support

### Modalities

- Small Molecule

### Development capabilities

- Analytical method development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)

## ESTEVE CDMO

- Profile: [/companies/esteve-cdmo](/companies/esteve-cdmo)

ESTEVE CDMO — ESTEVE CDMO is adding manufacturing capacity in the USA and China, including a $33 million expansion at its Morton Grove, Illinois site. Its China investment adds three manufacturing workshops with 250 m³ of total reaction volume, and its US assets add early development capabilities.

Services: 0. Modalities: 0. Indications: 0. Locations: 2. Certifications: 0. The strongest documented coverage currently appears in locations (2).

### Services

- Data not yet provided.

### Modalities

- Data not yet provided.

### Development capabilities

- Data not yet provided.

### Manufacturing capabilities

- Data not yet provided.